US Patent Forum 2013
The forum provides an opportunity to meet top officials, leading counsel at US corporations and their private practice advisers for a number of lively and informative panel sessions looking at strategic implications of US Patent Reform and the evolving landscape of Patents in the US in full context.
• Elegibility of gene patents - long term impact of the decisions on medical field • Enforcement of method claims and Akami v Limelight / McKesson v Epic cases • Apple v Samsung • Effective budgeting for the reforms and how to practice due diligence while monetizing your IP and looking after your bottom line.
Willard InterContinental / Washington DC, USA
For more information please visit US Patent Forum 2013
Willard InterContinental
1401 Pennsylvania Ave NW, Washington, DC
Washington, Washington DC, 20004
United States
Back
The process of invention is complete only with the IP protection provided in law. That's where MBM comes in. We match our clients' creative thinking with the creative protection needed to achieve their goals.
Health Canada recently announced that section 2.1 of its Guidance Document re: Data Protection has been amended to clarify that the prior approval of a medicinal ingredient in a drug for veterinary use will not preclude the granting of data protection for a drug for...
